PFS
GTBP icon

Prospera Financial Services’s GT Biopharma GTBP Stock Holding History

Prospera Financial Services’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.12K Buy
12,500
+504
+4% +$204 ﹤0.01% 1466
2026
Q1 		$4.89K Hold
11,996
– – ﹤0.01% 1416
2025
Q4 		$9.42K Buy
+11,996
New +$8.52K ﹤0.01% 1357

Other funds holding GTBP

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
OWA
Opal Wealth Advisors Jericho, New York $463M AUM 20.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
4WM
49 Wealth Management Austin, Texas $524M AUM 16.59% 1-Year Est. Return
A
Alongside Austin, Texas $525M AUM

Prospera Financial Services's GTBP Position: Q2 2026 in Review

Prospera Financial Services increased its GT Biopharma (GTBP) stake by 4.2% in Q2 2026, buying an estimated $204 and bringing the position to 12,500 shares worth $6.12K. The position accounts for ﹤0.01% of the portfolio, ranked #1466.

Prospera Financial Services first reported a position in GTBP in Q4 2025 and has held it in 3 quarters since. The position peaked at $9.42K in Q4 2025. 59 funds tracked by Wall St. Rank hold GTBP as of Q2 2026.

  • Prospera Financial Services held 12,500 shares of GT Biopharma worth $6.12K as of Q2 2026.
  • Prospera Financial Services bought 504 GT Biopharma shares in Q2 2026, an estimated $204.
  • GT Biopharma made up ﹤0.01% of Prospera Financial Services's portfolio in Q2 2026, its #1466 holding.
  • Prospera Financial Services first reported a position in GT Biopharma in Q4 2025 and has held it in 3 quarters since.
  • Prospera Financial Services's GT Biopharma position peaked at $9.42K in Q4 2025.
  • 59 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.